NexGelRx is a spin-off company developing prescription drug delivery solutions using proprietary hydrogel technology.
NexGelRx, has raised $1.3M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
NexGelRx,'s investors include Ariel Imas, Eric Gruntfest.
NexGelRx, is headquartered in Langhorne, United States.
NexGelRx is a spin-off company developing prescription drug delivery solutions using proprietary hydrogel technology.
NexGelRx, is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NexGelRx, — Funding & Investors." VCBacked, December 16, 2025, https://www.vcbacked.co/company/nexgelrx. Accessed October 4, 2026.
VCBacked. (2025). NexGelRx, — Funding & Investors. Retrieved October 4, 2026, from https://www.vcbacked.co/company/nexgelrx
{{cite web |title=NexGelRx, — Funding & Investors |url=https://www.vcbacked.co/company/nexgelrx |website=VCBacked |access-date=October 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated